JP2015525076A5 - - Google Patents

Download PDF

Info

Publication number
JP2015525076A5
JP2015525076A5 JP2015517428A JP2015517428A JP2015525076A5 JP 2015525076 A5 JP2015525076 A5 JP 2015525076A5 JP 2015517428 A JP2015517428 A JP 2015517428A JP 2015517428 A JP2015517428 A JP 2015517428A JP 2015525076 A5 JP2015525076 A5 JP 2015525076A5
Authority
JP
Japan
Prior art keywords
btv
ahsv
vector
rna
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015517428A
Other languages
English (en)
Japanese (ja)
Other versions
JP6347257B2 (ja
JP2015525076A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/045667 external-priority patent/WO2013188673A2/en
Publication of JP2015525076A publication Critical patent/JP2015525076A/ja
Publication of JP2015525076A5 publication Critical patent/JP2015525076A5/ja
Application granted granted Critical
Publication of JP6347257B2 publication Critical patent/JP6347257B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015517428A 2012-06-13 2013-06-13 再集合体btvおよびahsvワクチン Active JP6347257B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261659198P 2012-06-13 2012-06-13
US61/659,198 2012-06-13
PCT/US2013/045667 WO2013188673A2 (en) 2012-06-13 2013-06-13 Reassortant btv and ahsv vaccines

Publications (3)

Publication Number Publication Date
JP2015525076A JP2015525076A (ja) 2015-09-03
JP2015525076A5 true JP2015525076A5 (https=) 2016-05-26
JP6347257B2 JP6347257B2 (ja) 2018-06-27

Family

ID=49237584

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015517428A Active JP6347257B2 (ja) 2012-06-13 2013-06-13 再集合体btvおよびahsvワクチン

Country Status (17)

Country Link
US (1) US10801039B2 (https=)
EP (1) EP2861248B1 (https=)
JP (1) JP6347257B2 (https=)
KR (1) KR102136437B1 (https=)
CN (2) CN110628822A (https=)
AU (2) AU2013274191B2 (https=)
BR (1) BR112014031133B1 (https=)
CA (1) CA2876196C (https=)
ES (1) ES2664069T3 (https=)
IL (1) IL236148B (https=)
MA (1) MA37749B1 (https=)
MX (1) MX364875B (https=)
NZ (1) NZ703297A (https=)
RU (1) RU2656187C2 (https=)
TN (1) TN2014000518A1 (https=)
WO (1) WO2013188673A2 (https=)
ZA (1) ZA201409124B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11053509B2 (en) 2016-04-19 2021-07-06 Csir Plant-produced chimaeric Orbivirus VLPs
MA43503B2 (fr) * 2016-04-26 2021-02-26 London School Of Hyghiene & Tropical Medicine Arn viral simple brin isole (ssrna) derive du genome du virus de la peste equine (ahsv) pour la vaccination d'animaux contre le ahsv
CN110049994B (zh) * 2016-12-08 2023-05-02 拜西欧斯(北京)生物技术有限公司 一种缀合物及其应用
CN109897092B (zh) * 2019-04-02 2019-11-19 深圳海关动植物检验检疫技术中心 一种蓝舌病病毒非结构蛋白ns3的可溶制备方法
CN110016466B (zh) * 2019-05-21 2022-09-13 云南省畜牧兽医科学院 特异性检测蓝舌病病毒的单抗及其杂交瘤细胞株和应用
CN110257560B (zh) * 2019-07-23 2023-06-27 深圳海关动植物检验检疫技术中心 一种用于蓝舌病病毒8型检测的试剂、检测方法及应用
CN112375848A (zh) * 2020-12-11 2021-02-19 云南省畜牧兽医科学院 一种蓝舌病病毒血清型鉴定的RT-qPCR检测试剂盒和方法
CN116024183B (zh) * 2023-02-15 2023-10-31 中国农业科学院兰州兽医研究所 一种用于荧光染色的重组蓝舌病毒及其构建方法
CN120271699B (zh) * 2025-04-10 2026-03-31 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) 一株特异识别蓝舌病毒vp5蛋白的单克隆抗体

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US4708871A (en) 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
EP0173552B1 (en) 1984-08-24 1991-10-09 The Upjohn Company Recombinant dna compounds and the expression of polypeptides such as tpa
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4968615A (en) 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
US4963481A (en) 1985-12-18 1990-10-16 Genetics Institute Inc Promoter system
GB2197321B (en) 1986-09-12 1990-10-03 Genentech Inc Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
DE3743138A1 (de) 1987-12-18 1989-09-14 Mayr Christian Gmbh & Co Kg Schleifringlose, elektromagnetische ueberlastkupplung
DE69233158T2 (de) 1991-03-07 2004-05-13 Connaught Technology Corp., Greenville Gentechnologisch hergestellter stamm für impfstoffe
CA2214029A1 (en) 1995-04-25 1996-10-31 Magda Marquet Single-vial formulations of dna/lipid complexes
US5846946A (en) 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
FR2751226B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
FR2751225B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire
FR2751228B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
FR2751229B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751224B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
ES2241042T3 (es) 1996-10-11 2005-10-16 The Regents Of The University Of California Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora.
HUP0004589A3 (en) 1997-06-30 2003-08-28 Centre Nat Rech Scient Improved method for transferring nucleic acid into the striped muscle and combination therefor
FR2778858B1 (fr) 1998-05-20 2000-06-16 Oreal Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique
FR2801607B1 (fr) 1999-11-26 2001-12-28 Merial Sas Pneumovirus du canard et vaccins correspondants
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
SI1651265T1 (sl) 2003-07-24 2008-10-31 Merial Ltd Formulacije cepiva, ki obsegajo emulzijo olje v vodi
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
EP2062594A1 (en) * 2007-11-21 2009-05-27 Wyeth Farma, S.A. Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
KR101718497B1 (ko) * 2007-11-26 2017-03-22 런던 스쿨 오브 하이진 앤 트로피컬 메디신 레오바이러스과 바이러스의 백신용 바이러스 균주를 제조하는 방법

Similar Documents

Publication Publication Date Title
JP2015525076A5 (https=)
RU2015100269A (ru) Реассортантные btv и ahsv вакцины
ES2662801T3 (es) Vacunas atenuadas contra Streptoccocus suis y procedimientos de fabricación y uso de las mismas
RU2017113571A (ru) Рекомбинантные вакцины от fmdv и их применение
CL2019002280A1 (es) Vectores virales, adenovirales y composiciones a base de una secuencia de ornitina transcarbamilasa humana (hotch) modificada genéticamente y su uso en el tratamiento de deficiencia de la otc. (divisional solicitud 201602235)
CL2018003769A1 (es) Una cepa del virus atenuado de la peste porcina africana desarrollada racionalmente que, protege contra la infección por el virus parental georgia 2007 aislado.
PE20141482A1 (es) Vectores recombinantes de hvt que expresan antigenos de patogenos de aves y sus usos
JP2015524421A5 (https=)
CL2012000447A1 (es) Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica.
MX2018007860A (es) Vacunas recombinantes contra el zika.
AR134554A2 (es) Composición inmunológica o de vacuna y método para producir una respuesta protectora contra prrsv en un animal
AR080515A1 (es) Vacunas recombinantes del virus de la enfermedad del pie y de la boca (fmd1) y sus usos
JP2009523422A5 (https=)
FI3539565T3 (fi) Koostumuksia ja menetelmiä dengue-viruksen kimeerisille rakenteille rokotteissa
NZ598605A (en) Vaccine against african horse sickness virus
JP2015511948A5 (https=)
JP2013520977A5 (https=)
HRP20240163T1 (hr) Metode i pripravci za izazivanje zaštitnog imuniteta protiv infekcije filovirusom
CO6541529A2 (es) Método, plasmideo y composición para inducir una respuesta inmune contra virus de la dengue basado en vacunas de adn y virus quimericos
WO2018102774A3 (en) Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein a
AR082281A1 (es) Vectores de parapoxvirus
MX338052B (es) Vectores de parapoxvirus que contienen el antigeno del virus de la rabia.
JP2009522368A5 (https=)
JP2014523250A5 (https=)
JP2017526366A5 (https=)